Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | CDK1 | P06493 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL694106 | 0.84 | GAA (0.41) | GAACDK1MAPTALDH1A1KDM4E | |
| Iodosulfuron SCHEMBL29686924 | 0.82 | CDK1 (0.42) | GAACDK1ALOX15MAPTALDH1A1 | |
| Iodosulfuron SCHEMBL119814 | 0.82 | CDK1 (0.42) | GAACDK1ALOX15MAPTALDH1A1 | |
| Iodosulfuron SCHEMBL29355338 | 0.82 | CDK1 (0.42) | GAACDK1ALOX15MAPTALDH1A1 | |
| Iodosulfuron SCHEMBL7638003 | 0.82 | CDK1 (0.42) | GAACDK1ALOX15MAPTALDH1A1 | |
| Iodosulfuron SCHEMBL6061256 | 0.82 | CDK1 (0.42) | GAACDK1ALOX15MAPTALDH1A1 | |
| Iodosulfuron SCHEMBL21582014 | 0.82 | CDK1 (0.42) | GAACDK1ALOX15MAPTALDH1A1 | |
| Iodosulfuron SCHEMBL16670263 | 0.82 | CDK1 (0.42) | GAACDK1ALOX15MAPTALDH1A1 | |
| SCHEMBL2622465 | 0.81 | GAA (0.39) | GAAALOX15MAPTALDH1A1KDM4E | |
| Iodosulfuron SCHEMBL1807658 | 0.81 | CDK1 (0.41) | GAACDK1ALOX15MAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7135434-B2 | Herbicidally active composition comprising a mixture of A. a herbicidally active amount of one or more compounds of the | HOECHST SCHERING AGREVO GMBH (DE) | 2006-11-14 | — | — | US | disclosed |
| US-6914035-B2 | Combinations of herbicides and safeners | BAYER CROPSCIENCE GMBH (DE) | 2005-07-05 | — | — | US | disclosed |
| US-20030171220-A1 | Combinations of herbicides and safeners | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2003-09-11 | — | — | US | disclosed |
| US-20030130120-A1 | Combinations of herbicides and safeners | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2003-07-10 | — | — | US | disclosed |
| US-6511940-B1 | Mixture of isoxazole derivative or cyclohexen-3-one derivative with antidote comprising quinoline, isoxazole, pyrazole or N-acylsulfonamide derivative | HOECHST SCHERING AGREVO GMBH (DE) | 2003-01-28 | — | — | US | disclosed |
| US-6211118-B1 | Herbicidal compositions | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-04-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030171220-A1 | Combinations of herbicides and safeners | DDT, CYP2B6, CYP2A6 | GAA 526/4885CDK1 3803/4885ALOX15 1765/4885 |
| US-20030130120-A1 | Combinations of herbicides and safeners | DDT, GSTO1, CYP2W1 | GAA 503/4885CDK1 3679/4885ALOX15 1844/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.